Annovis Bio Inc (ANVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,854 | -24,590 | -56,204 | -25,329 | -14,487 |
| Accounts payable and accrued liabilities | 285 | 1,013 | -2,668 | 3,273 | 346 |
| Other Working Capital | 1,579 | 682 | -229 | -1,137 | 657 |
| Other Operating Activity | 1,371 | 1,001 | 19,134 | 5,879 | 4,351 |
| Operating Cash Flow | $-25,620 | $-21,895 | $-39,967 | $-17,313 | $-9,132 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 34,600 | 26,692 | 17,344 | 5 | 46,744 |
| Financing Cash Flow | $34,600 | $26,692 | $17,344 | $5 | $46,744 |
| Beginning Cash Position | 10,552 | 5,755 | 28,378 | 45,686 | 8,075 |
| End Cash Position | 19,532 | 10,552 | 5,755 | 28,378 | 45,686 |
| Net Cash Flow | $8,980 | $4,797 | $-22,623 | $-17,308 | $37,611 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,620 | -21,895 | -39,967 | -17,313 | -9,132 |
| Free Cash Flow | -25,620 | -21,895 | -39,967 | -17,313 | -9,132 |